In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes

American Heart Journal

Volumn 154, Issue 6, 2007, Pages 1184-1190

  Vis, Marije M ^a   Sjauw, Krischan D ^a   van der Schaaf, René J ^a   Baan Jr , Jan ^a   Koch, Karel T ^a   DeVries, J Hans ^a   Tijssen, Jan G P ^a   de Winter, Robbert J ^a   Piek, Jan J ^a   Henriques, José P S ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION; TREATMENT OUTCOME;

AGED; BLOOD GLUCOSE; COHORT STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS; SHOCK, CARDIOGENIC;

EID: 36148966988     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.07.028     Document Type: Article

References (33)

1. Hasdai D., Topol E.J., Califf R.M., et al. Cardiogenic shock complicating acute coronary syndromes. Lancet 356 (2000) 749-756
2. Babaev A., Frederick P.D., Pasta D.J., et al. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 294 (2005) 448-454
3. Bouki K.P., Pavlakis G., and Papasteriadis E. Management of cardiogenic shock due to acute coronary syndromes. Angiology 56 (2005) 123-130
4. Dzavik V., Sleeper L.A., Cocke T.P., et al. Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J 24 (2003) 828-837
5. Jeger R.V., Harkness S.M., Ramanathan K., et al. Emergency revascularization in patients with cardiogenic shock on admission: a report from the SHOCK trial and registry. Eur Heart J 27 (2006) 664-670
6. Timmer J.R., van der Horst I.C., Ottervanger J.P., et al. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J 148 (2004) 399-404
7. Capes S.E., Hunt D., Malmberg K., et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 (2000) 773-778
8. Zeller M., Cottin Y., Brindisi M.C., et al. Impaired fasting glucose and cardiogenic shock in patients with acute myocardial infarction. Eur Heart J 25 (2004) 308-312
9. Expert Committee on the Diagnostics and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 Suppl 1 (2003) S5-S20
10. Bartnik M., Ryden L., Ferrari R., et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 25 (2004) 1880-1890
11. Hochman J.S., Boland J., Sleeper L.A., et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry SHOCK Registry Investigators. Circulation 91 (1995) 873-881
12. Page D.L., Caulfield J.B., Kastor J.A., et al. Myocardial changes associated with cardiogenic shock. N Engl J Med 285 (1971) 133-137
13. Hutchins G.M., and Bulkley B.H. Infarct expansion versus extension: two different complications of acute myocardial infarction. Am J Cardiol 41 (1978) 1127-1132
14. Braunwald E., and Kloner R.A. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 66 (1982) 1146-1149
15. Grines C.L., Topol E.J., Califf R.M., et al. Prognostic implications and predictors of enhanced regional wall motion of the noninfarct zone after thrombolysis and angioplasty therapy of acute myocardial infarction. The TAMI Study Groups. Circulation 80 (1989) 245-253
16. Picard M.H., Davidoff R., Sleeper L.A., et al. Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock. Circulation 107 (2003) 279-284
17. Oliver M.F., and Opie L.H. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 343 (1994) 155-158
18. Collet J.P., and Montalescot G. The acute reperfusion management of STEMI in patients with impaired glucose tolerance and type 2 diabetes. Diab Vasc Dis Res 2 (2005) 136-143
19. Iwakura K., Ito H., Ikushima M., et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 41 (2003) 1-7
20. Shechter M., Merz C.N., Paul-Labrador M.J., et al. Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease. J Am Coll Cardiol 35 (2000) 300-307
21. Marfella R., Esposito K., Giunta R., et al. Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation 101 (2000) 2247-2251
22. Title L.M., Cummings P.M., Giddens K., et al. Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E. J Am Coll Cardiol 36 (2000) 2185-2191
23. Kersten J.R., Toller W.G., Tessmer J.P., et al. Hyperglycemia reduces coronary collateral blood flow through a nitric oxide-mediated mechanism. Am J Physiol Heart Circ Physiol 281 (2001) H2097-H2104
24. Ambrosio G., Weisman H.F., Mannisi J.A., et al. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 80 (1989) 1846-1861
25. Wu K.C., Zerhouni E.A., Judd R.M., et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97 (1998) 765-767
26. Montalescot G., Antoniucci D., Dastrati A., et al. Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow up. Eur Heart J 28 (2007) 443-449
27. Hasdai D., Harrington R.A., Hochman J.S., et al. Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. J Am Coll Cardiol 36 (2000) 685-692
28. Mehta S.R., Yusuf S., Diaz R., et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 293 (2005) 437-446
29. vanderHorst I., Zijlstra F., van't Hof A.W., et al. Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction. The glucose-insulin-potassium study: a randomized trial. J Am Coll Cardiol 42 (2003) 784-791
30. Malmberg K., Ryden L., Efendic S., et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 26 (1995) 57-65
31. VandenBerghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
32. Nikolaidis L.A., Mankad S., Sokos G.G., et al. Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion. Circulation 109 (2004) 962-965
33. Nikolaidis L.A., Elahi D., Shen Y.T., et al. Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 289 (2005) H2401-H2408